Protalix BioTherapeutics, Inc. (NYSE:PLX) announced a collaboration with the Germany-based Secarna Pharmaceuticals to develop novel antisense oligonucleotide (ASO) therapies using Secarna’s ...

Fintel reports that on November 21, 2025, HC Wainwright & Co. maintained coverage of Protalix BioTherapeutics (NYSEAM:PLX) with a Buy recommendation. Analyst Price Forecast Suggests 720.69% Upside As ...

Protalix BioTherapeutics, Inc. (NYSE:PLX) announced 3Q:25 financial and operational results in a November 13th, 2025, press release and in its Form 10-Q filing. The reports were followed by a ...

Fabry disease is a rare genetic lysosomal storage disorder in which the body lacks sufficient amounts of an enzyme that breaks down fats. The companies requested to approve the dosing regimen of 2 ...

Sgt. Brenden Lopez uses a computer on Joint Base Lewis-McChord, Washington, for a four-session online intervention designed to improve connection with and promote the care of one’s body. (Christopher ...

$PLX ($PLX) is expected to release its quarterly earnings data on Monday, March 17th before market open, per Finnhub. Analysts are expecting revenue of $18,940,530 ...

Protalix Biotherapeutics, Inc. (NYSE:PLX) finds itself in an enviable position as we begin 2025. The company has two approved products generating revenues and a pipeline with multiple candidates in ...

Fieldmade, a mobile and deployable AM solutions provider, and Plastometrex, a materials testing company, have entered a partnership to bring quality assurance to the forefront of on-demand metal AM.

Most workers (70%) say they currently have the education and training they need to get ahead in their job or career. Still, a sizable share (30%) say they need more education and training. Not ...

Army Training Network Interactive Training Doctrine, "How to conduct a training meeting." Training doctrine recognizes the need for training management to be routine and predictable. Army Doctrine ...